companies making glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our 9 Companies Developing Next-Generation GLP-1

Angiogenesis is a crucial process for healing and recovery in many tissues

A2AR antagonists triggered the AMPK/m-TOR autophagic pathway to reverse the calcium-dependent cell damage in 6-OHDA induced model of PD

The range includes phosphatidylcholine, phospholipid complex oils, butyrate and mineral formulations, with particular focus on membrane and mitochondrial health

"This can be from inflammatory conditions like acne or eczema, injury to the skin, hormonal conditions, medications, and sunlight." This is because acne, sunlight, and skin rashes have the potential to stimulate melanocytes the pigment-making cells in the skin to make a surplus of pigment